Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-054661
Filing Date
2004-11-24
Accepted
2004-11-24 15:35:29
Documents
1
Period of Report
2004-11-15

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION boc90010_01jaw.html 4  
1 MAIN DOCUMENT DESCRIPTION boc90010_01jaw.xml 4 3867
  Complete submission text file 0001209191-04-054661.txt   5824
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089 8472796100
AKORN INC (Issuer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKORN INC 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089
Business Address C/O MEDICHEM LIFE SCIENCES INC 12305 SOUTH NEW AVENUE LEMONT IL 60439 8472796100
WHITNELL JEFFREY A (Reporting) CIK: 0001126562 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32360 | Film No.: 041167165